In brief
The Therapeutic Goods Administration announced reforms to tighten sunscreen regulation after several products failed to meet their labeled SPF levels in independent tests. The changes focus on stronger testing protocols, quality standards for key ingredients, and tighter limits on SPF claims, with further consultation planned before implementation. Industry and consumer groups have responded to the 2024 public consultation, and the reforms aim to improve confidence and reduce skin‑cancer incidence in a country with the world’s highest rates.
Australia’s Therapeutic Goods Administration (TGA) unveiled a set of reforms on Tuesday designed to tighten the regulation of sunscreen products, citing growing concerns that some commercially available lotions fail to deliver the sun‑protection factor (SPF) they claim.
The proposed changes come after independent laboratory tests revealed several brands were unable to meet the SPF levels listed on their packaging, prompting questions about consumer protection and the prevalence of skin cancer in the country.
The TGA’s statement said the reforms would “strengthen sunscreen testing requirements, set quality standards for specific ingredients and limit the SPF claims that cosmetic sunscreens can make.” It also announced a review of good‑manufacturing‑practice guidance to clarify expectations and responsibilities for industry, aiming to maintain confidence in the performance of sunscreens available in Australia.
In a key quote, David Whiteman, a distinguished scientist at QIMR Berghofer Medical Research Institute, backed the proposed reforms. "These changes will improve the rigor and transparency of sunscreen testing and review manufacturing practices," he said, citing reports that some sunscreens failed to meet their labelled SPF in independent tests.
SPF claims have long been a sticking point for regulators. The TGA noted that while sunscreen can provide crucial protection against harmful ultraviolet radiation, the reliability of advertised SPF levels has been undermined by inconsistent testing methodology and inadequate ingredient validation.
The agency highlighted that Australia remains the country with the highest incidence of skin cancer worldwide, stressing that the primary objective of sunscreen regulation is to safeguard public health by ensuring product quality, safety, and efficacy.
During the March‑to‑May public consultation, the TGA received almost 120 submissions from a broad spectrum of stakeholders, including industry representatives, testing laboratories, health professionals, consumer groups, and academia. The reactions ranged from support for stricter standards to concerns about potential market impacts and the burden of compliance.
Industry participants argued that the existing regulations already provide a robust framework and that the new rules might impose redundancy and cost. Consumer groups, on the other hand, urged the TGA to act swiftly to eliminate misleading claims that could compromise avoidable skin‑cancer diagnosis.
The TGA already plans an additional round of consultation specifically focused on SPF labeling. The agency said it would “review the evidence and gather further input on the proposed limits before moving forward.”
Beyond testing and labeling, the proposal includes introducing mandatory ingredient quality checks for key protective compounds as well as revised guidelines for manufacturing practices, to prevent sub‑standard formulations from reaching the Australian market.
Previous research findings have shown that inadequate testing and poor ingredient quality can significantly reduce the real‑world effectiveness of sunscreen products, undermining public confidence and potentially increasing the long‑term health cost burden of a country suffering the highest skin‑cancer rates.
The TGA’s initiative arrives at a time when consumer awareness of skin health is rising, and global attention to the efficacy of sun‑protective products is increasing. Experts say that reliable SPF claims are crucial not only for individual safety but also for reducing the health system’s overall burden of skin‑cancer treatment.
Looking ahead, the TGA warned that without meaningful reforms, consumer trust could erode and health impacts could worsen. The proposed measures aim to reassure Australians that the sun protection they purchase meets the safety and performance standards necessary to protect them from UV radiation.
While the reforms still require further deliberation, especially regarding SPD labeling limits, the government’s move signals a clear intent to align sunscreen regulation with contemporary scientific evidence and public health expectations.
